2019
Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study
Goedel WC, King MRF, Lurie MN, Galea S, Townsend JP, Galvani AP, Friedman SR, Marshall BDL. Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study. Clinical Infectious Diseases 2019, 70: 1096-1102. PMID: 31143944, PMCID: PMC7319062, DOI: 10.1093/cid/ciz321.Peer-Reviewed Original ResearchConceptsSyringe services programHuman immunodeficiency virusHuman immunodeficiency virus (HIV) transmissionMore HIV infectionsInjection drug useHarm reduction servicesRural countiesScott CountyHIV infectionHIV transmissionImmunodeficiency virusDecrease incidenceHIV outbreakIncidence rateFirst infectionEarly infectionDrug useSingle infectionInfectionIncidenceVirus transmissionPWIDService programsDrugsTimely implementationEstimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States
Elion RA, Kabiri M, Mayer KH, Wohl DA, Cohen J, Beaubrun AC, Altice FL. Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States. International Journal Of Environmental Research And Public Health 2019, 16: 1592. PMID: 31067679, PMCID: PMC6539923, DOI: 10.3390/ijerph16091592.Peer-Reviewed Original ResearchConceptsYoung Latino MSMYoung Black MSMPre-exposure prophylaxisBlack MSMLatino MSMPrEP useHIV Incidence Risk IndexHuman immunodeficiency virus (HIV) transmissionUse of PrEPNon-PrEP usersLowest NNTHIV infectionNNT valuesHIV prevalenceHIV epidemicHIV preventionMSM populationSubsequent infectionInfection reductionMSMPrevalenceIncidenceVirus transmissionPrEPProphylaxis
2016
Acceptability and feasibility of mHealth and community-based directly observed antiretroviral therapy to prevent mother-to-child HIV transmission in South African pregnant women under Option B+: an exploratory study
Nachega JB, Skinner D, Jennings L, Magidson JF, Altice FL, Burke JG, Lester RT, Uthman OA, Knowlton AR, Cotton MF, Anderson JR, Theron GB. Acceptability and feasibility of mHealth and community-based directly observed antiretroviral therapy to prevent mother-to-child HIV transmission in South African pregnant women under Option B+: an exploratory study. Patient Preference And Adherence 2016, 10: 683-690. PMID: 27175068, PMCID: PMC4854240, DOI: 10.2147/ppa.s100002.Peer-Reviewed Original ResearchFeasibility of mHealthHIV status disclosurePregnant womenAntiretroviral therapyTreatment supportersStatus disclosureChild human immunodeficiency virus (HIV) transmissionCommunity primary care clinicsHuman immunodeficiency virus (HIV) transmissionPregnant South African womenART adherence interventionsAntiretroviral therapy regimenChild HIV transmissionAntiretroviral therapy adherencePrimary care clinicsSouth African pregnant womenMobile phone accessAfrican pregnant womenFocus group discussionsSMS text messagingPMTCT servicesSouth African womenART adherencePhone accessTherapy regimen
2006
Opioid Dependence: Rationale for and Efficacy of Existing and New Treatments
Fiellin DA, Friedland GH, Gourevitch MN. Opioid Dependence: Rationale for and Efficacy of Existing and New Treatments. Clinical Infectious Diseases 2006, 43: s173-s177. PMID: 17109303, DOI: 10.1086/508180.BooksConceptsOpioid agonist treatmentOpioid dependenceAgonist treatmentHuman immunodeficiency virus (HIV) transmissionBuprenorphine/naloxone combinationNeurobiological basisOpioid withdrawalBuprenorphine treatmentHIV infectionDecreased riskNaloxone combinationOpioid receptorsGeneral physiciansMedical disordersNew treatmentsMethadoneVirus transmissionBuprenorphineTreatmentMedicationsPatientsChronicInfectionIntracellular processesPhysicians
2005
Does Severity of HIV Disease in HIV-Infected Mothers Affect Mortality and Morbidity among Their Uninfected Infants?
Kuhn L, Kasonde P, Sinkala M, Kankasa C, Semrau K, Scott N, Tsai WY, Vermund SH, Aldrovandi GM, Thea DM. Does Severity of HIV Disease in HIV-Infected Mothers Affect Mortality and Morbidity among Their Uninfected Infants? Clinical Infectious Diseases 2005, 41: 1654-1661. PMID: 16267740, PMCID: PMC1351118, DOI: 10.1086/498029.Peer-Reviewed Original ResearchConceptsMonths of ageUninfected infantsHIV diseaseAdvanced diseasePerinatal human immunodeficiency virus (HIV) transmissionAdvanced maternal HIV diseaseHuman immunodeficiency virus (HIV) transmissionHIV-uninfected infantsLower child weightMaternal HIV diseaseMaternal viral loadT-cell countsCells/microLLow birth weightInfants of mothersHealth of infantsMonths of lifeMaternal diseaseHIV infectionHospital admissionImmune dysfunctionInfant weightMaternal deathsViral loadBirth weight
2002
Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990–2001
Heimer R, Clair S, Teng W, Grau LE, Khoshnood K, Singer M. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990–2001. Journal Of Urban Health 2002, 79: 556-570. PMID: 12468675, PMCID: PMC3456719, DOI: 10.1093/jurban/79.4.556.Peer-Reviewed Original ResearchConceptsSyringe exchange programsClean syringesHuman immunodeficiency virus (HIV) prevalenceHuman immunodeficiency virus (HIV) transmissionSyringe exchange useSyringe trackingHIV riskSyringe availabilityNumber of syringesVirus prevalenceVirus transmissionSyringesVisitsRiskNew HavenEffect of legislationPrevalenceExpression of DC-SIGN by Dendritic Cells of Intestinal and Genital Mucosae in Humans and Rhesus Macaques
Jameson B, Baribaud F, Pöhlmann S, Ghavimi D, Mortari F, Doms RW, Iwasaki A. Expression of DC-SIGN by Dendritic Cells of Intestinal and Genital Mucosae in Humans and Rhesus Macaques. Journal Of Virology 2002, 76: 1866-1875. PMID: 11799181, PMCID: PMC135921, DOI: 10.1128/jvi.76.4.1866-1875.2002.Peer-Reviewed Original ResearchConceptsDC-SIGN expressionDendritic cellsDC-SIGNHuman immunodeficiency virus (HIV) transmissionRhesus macaquesDC-SIGNR expressionDistinct DC populationsSolitary lymphoid nodulesSubepithelial dendritic cellsSubepithelial dome regionTriple colour analysisPlasmacytoid dendritic cellsVirus transmissionDC-SIGNRIntact vaginal mucosaSpecific ICAM-3DC populationsHIV coreceptorsGenital mucosaLangerhans cellsPeyer's patchesGenital tractTerminal ileumInterfollicular regionsVaginal epithelium
1998
Drug abuse treatment success among needle exchange participants.
Brooner R, Kidorf M, King V, Beilenson P, Svikis D, Vlahov D. Drug abuse treatment success among needle exchange participants. Public Health Reports 1998, 113 Suppl 1: 129-39. PMID: 9722818, PMCID: PMC1307735.Peer-Reviewed Original ResearchConceptsNeedle exchange programsOpioid agonist treatment programStandard referral groupTreatment programReferral groupBetter short-term treatment outcomesNew admissionsDrug useHuman immunodeficiency virus (HIV) transmissionShort-term treatment outcomesDrug abuse treatment clinicsGreater baseline severitySelf-reported drug useDrug abuse treatment programsUse of drugsReferral patientsClinical variablesBaseline severityIncidence rateTreatment successTreatment clinicsTreatment outcomesBaseline differencesTreatment responseOutcome measures
1997
Postcoital Vaginal Bleeding as a Risk Factor for Transmission of the Human Immunodeficiency Virus in a Heterosexual Partner Study in Brazil
Guimarães M, Vlahov D, Castilho E. Postcoital Vaginal Bleeding as a Risk Factor for Transmission of the Human Immunodeficiency Virus in a Heterosexual Partner Study in Brazil. JAMA Internal Medicine 1997, 157: 1362-1368. PMID: 9201011, DOI: 10.1001/archinte.1997.00440330102012.Peer-Reviewed Original ResearchConceptsPostcoital vaginal bleedingHIV infectionVaginal bleedingRisk factorsAnal sexMale partnersPostcoital bleedingFemale partnersCondom useHuman immunodeficiency virus (HIV) transmissionSexual contactAdvanced HIV infectionHuman immunodeficiency virusInconsistent condom useHIV positivityAIDS CenterHIV serostatusImmunodeficiency syndromeImmunodeficiency virusHeterosexual contactBleedingEligibility criteriaVaginal sexPartner studiesInfection
1995
Zidovudine for the Prevention of Vertical HIV Transmission
Rouse D, Owen J, Goldenberg R, Vermund S. Zidovudine for the Prevention of Vertical HIV Transmission. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 9: 401-407. PMID: 7600108, DOI: 10.1097/00042560-199508000-00011.Peer-Reviewed Original ResearchConceptsCongenital HIV infectionZDV useHIV infectionVertical human immunodeficiency virus (HIV) transmissionHuman immunodeficiency virus (HIV) transmissionAdverse effectsVertical HIV transmissionDrug-induced complicationsQuality-adjusted life yearsMarkov cohort simulationQuality of lifeDecision analysis modelUninfected childrenZDV therapyZDV treatmentAsymptomatic HIVNeonatal exposureZidovudine administrationHIV transmissionPregnant womenLife decrementsHypothetical cohortLife yearsCohort simulationHIV
1994
HIV infection and cocaine use in methadone maintained and untreated intravenous drug users
Meandzija B, O'Connor P, Fitzgerald B, Rounsaville B, Kosten T. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug And Alcohol Dependence 1994, 36: 109-113. PMID: 7851277, DOI: 10.1016/0376-8716(94)90092-2.Peer-Reviewed Original ResearchConceptsIntravenous drug usersMethadone maintenance treatmentMethadone maintenance programHIV infectionCocaine useMore cocaine useMaintenance treatmentRisk factorsDrug usersMethadone maintenance treatment groupHuman immunodeficiency virus (HIV) transmissionAfrican AmericansMaintenance treatment groupNon-infected subjectsInjection frequencyHIV-negativeHIV testingDrug injectionStratified analysisTreatment groupsTotal cocaineHIVRisk behaviorsGreater riskInfectionDrug‐related behavior change for HIV transmission among American injection drug users
CELENTANO D, MUÑOZ A, CORN S, NELSON K, VLAHOV D. Drug‐related behavior change for HIV transmission among American injection drug users. Addiction 1994, 89: 1309-1317. PMID: 7804092, DOI: 10.1111/j.1360-0443.1994.tb03310.x.Peer-Reviewed Original ResearchConceptsInjection drug usersSeropositive injection drug usersRisk behaviorsHIV infectionDrug usersActive injection drug usersDrug-related risk behaviorsHuman immunodeficiency virus (HIV) transmissionHigh-risk drug-related behaviorsSemi-annual visitsMultiple logistic regressionBehavior changeGreater risk reductionDrug-related behaviorsLow-risk behaviorsSeropositive participantsHIV serostatusHIV transmissionLongitudinal cohortVaccine developmentPrevention programsLogistic regressionAIDS epidemicVirus transmissionBehavior maintenanceCorrelates of needle sharing among injection drug users.
Mandell W, Vlahov D, Latkin C, Oziemkowska M, Cohn S. Correlates of needle sharing among injection drug users. American Journal Of Public Health 1994, 84: 920-3. PMID: 8203687, PMCID: PMC1614968, DOI: 10.2105/ajph.84.6.920.Peer-Reviewed Original ResearchConceptsInjection drug usersRecent needle sharingNeedle sharingDrug usersActive injection drug usersHuman immunodeficiency virus (HIV) transmissionInjection drug usePotential risk factorsLow socioeconomic statusDrug use variablesDrug use practicesInjection equipmentRisk factorsDrug useMultivariate analysisHistory of arrestBisexual menSocioeconomic statusVirus transmissionDemographic factorsLife eventsHeterosexual counterpartsUse variablesNeedle
1989
Needle injuries among pediatric housestaff physicians in New York City.
Melzer SM, Vermund SH, Shelov SP. Needle injuries among pediatric housestaff physicians in New York City. 1989, 84: 211-4. PMID: 2748246, DOI: 10.1542/peds.84.2.211.Peer-Reviewed Original ResearchConceptsPediatric house officersNeedle injuryHIV infectionHouse officersHuman immunodeficiency virus (HIV) transmissionPediatric training programsNeedle puncture woundsOccupational HIV infectionPossible HIV exposureCumulative incidenceHIV exposureHIV testingHousestaff physiciansPatient's bloodInjuryPuncture woundsTraining programOccupational riskSignificant riskYears of trainingVirus transmissionBloodHIVInfectionRetrospective informationNeedles That Kill: Modeling Human Immunodeficiency Virus Transmission via Shared Drug Injection Equipment in Shooting Galleries
Kaplan E. Needles That Kill: Modeling Human Immunodeficiency Virus Transmission via Shared Drug Injection Equipment in Shooting Galleries. Clinical Infectious Diseases 1989, 11: 289-298. PMID: 2704927, DOI: 10.1093/clinids/11.2.289.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusDrug injection equipmentInfectivity of HIVDrug usersHuman immunodeficiency virus (HIV) transmissionInjection equipmentIntravenous drug usersCase notification dataHIV infectiousnessIntravenous transmissionImmunodeficiency virusAIDS casesNotification dataU.S. CentersShooting galleriesDisease controlVirus transmissionDrug addictsAIDSAddictsRapid spreadPopulationBloodInfectiousnessMonths
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply